Pharsight Monthly Summary
March, 2023
Recent happenings in patent protected drugs.
spacer_11
At a Glance
69
drug patents lapsed
Photos
79
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
ADAMIS PHARMS CORP
 
AMYLYX
 
ANTARES PHARMA INC
 
AXSOME MALTA
 
BEIGENE
 
BOEHRINGER INGELHEIM
 
BRISTOL
 
CMP DEV LLC
 
DECIPHERA PHARMS
 
EISAI INC
 
GENENTECH INC
 
GLAXOSMITHKLINE
 
HELSINN HLTHCARE
 
INCYTE CORP
 
LOXO ONCOL
 
MEDICINES360
 
NEXUS PHARMS
 
NORTON WATERFORD
 
NOVARTIS
 
NOVEN PHARMS INC
 
OPTINOSE US INC
 
SLAYBACK PHARMA LLC
 
STEMLINE THERAP
 
TEVA
 
TEVA BRANDED PHARM
 
TEVA PHARM
 
THERACOSBIO
 
TOLMAR
 
TRIS PHARMA INC
 
VANDA PHARMS INC
 
VERTEX PHARMS
 
VERTEX PHARMS INC
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADDYI SPROUT PHARMS
AMLODIPINE BESYLATE SYNTHON PHARMS
BANZEL EISAI INC
BEYAZ BAYER HLTHCARE
CAPRELSA GENZYME CORP
CHANTIX PF PRISM CV
COMBIGAN ALLERGAN
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
FOLOTYN ACROTECH
FUSILEV ACROTECH
LEXAPRO ALLERGAN
LUSEDRA EISAI INC
MACRILEN NOVO
SAXENDA NOVO
TEFLARO ALLERGAN
TOVIAZ PFIZER
VELCADE TAKEDA PHARMS USA
VIIBRYD ALLERGAN
VIMPAT UCB INC
VYVANSE TAKEDA PHARMS USA
ZIOPTAN AKORN
Drug patents lapsed
Drug Patent Patent expiry
AKYNZEO US6297375 Mar, 2023
BINOSTO US7964212 Mar, 2023
CHLORAPREP ONE-STEP US6729786 Mar, 2023
CHLORAPREP ONE-STEP US7241065 Mar, 2023
DALIRESP US8431154 Feb, 2023
DALIRESP US9468598 Feb, 2023
DIFFERIN US7834060 Mar, 2023
See more
Newly introduced Drug Patents
Drug Patent Patent expiry
AKYNZEO US11559523 Nov, 2030
ARMONAIR DIGIHALER US11357935*PED Mar, 2039
ARMONAIR DIGIHALER US11439777*PED Nov, 2040
ARMONAIR DIGIHALER US11464923*PED Dec, 2040
ATORVALIQ US11369567 Jun, 2037
AUSTEDO US11564917 Mar, 2036
AUSTEDO XR US8524733 Apr, 2031
See more
Recent patent litigations
Patent Petitioner Proceeding Date
US10272083 Sandoz Inc. 2023-02-03
US7713947 Hopewell Pharma Ventures, Inc. et al. 2023-01-23
US8377903 Hopewell Pharma Ventures, Inc. et al. 2023-01-23
US7713947 TWi Pharmaceuticals, Inc. 2022-10-14
US8377903 TWi Pharmaceuticals, Inc. 2022-10-14
US11110087 Dr. Reddy's Laboratories, Inc. et al. 2022-10-14
US7041786 MSN Laboratories Private Ltd. 2022-10-12
See in detail
What's new on Pharsight!

Patent families: Uncovering the Protected Places!

A patent family is like a group of siblings, all protecting the same invention or product under different patent offices. To launch a generic drug, it's important to know all the patents in the family, when they'll grow up and leave (expire), and any legal drama they may have. It can help you with simple questions like I have a generic in the US, but can I launch the same in India? This info affects when you can launch your generic, how successful it will be, and who your competitors will be. So, think of it as doing a background check on your future market before diving in!

Get ready for some serious legal battles!

We have a special page all about drugs that are protected by patents which act as a competitive advantage. To bypass this protection, oftentimes these patents are argued in court. The outcome can affect when generic versions of the drug become available and how much they cost.

Check out recent patent litigations

spacer_11
View past newsletters
November, 2022
December, 2022
January, 2023
February, 2023

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

© 2023 GreyB Research